RDY
Dr. Reddy's Laboratories Ltd
Company Overview
| Mkt Cap | $12.18B | Price | $13.29 |
| Volume | 1.45M | Change | -1.19% |
| P/E Ratio | 0.2 | Open | $13.32 |
| Revenue | $279.2B | Prev Close | $13.45 |
| Net Income | $55.7B | 52W Range | $12.26 - $16.17 |
| Div Yield | 0.09% | Target | $16.20 |
| Overall | 42 | Value | -- |
| Quality | 39 | Technical | 45 |
No chart data available
Stock Overview
Updated DailyDr. Reddy's Laboratories Ltd (RDY) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $13.29 with a market capitalization of $12.18 billion. The stock is in the lower portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows RDY with a volume of 1.45 million shares. The stock opened down 0.97% from yesterday's close of $13.45. Current analyst estimates project earnings of $0.74 per share for this year, with next year targeting $0.61.
RDY demonstrates weak technical indicators based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including PFE, TEVA, NVS, GSK, CPLFY.
Key investment considerations for RDY include below-average investment characteristics. The company offers a dividend yield of 0.093311% and analyst price targets suggest potential upside of 21.9%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 09:07 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RDY | $13.29 | -1.2% | 1.45M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dr. Reddy's Laboratories Ltd Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW